Polyreactivity of antibody molecules

Trends in Immunology

Volumn 25, Issue 4, 2004, Pages 174-179

  Notkins, Abner Louis ^a,b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BINDING SITE; COLOSTRUM; CONFORMATIONAL TRANSITION; HUMAN; IMMUNE SYSTEM; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPATHOLOGY; IMMUNOREGULATION; MUCOSAL IMMUNITY; NONHUMAN; REVIEW; SALIVATION;

EID: 1642315560     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2004.02.004     Document Type: Article

References (51)

1. Tauber A.I., Podolsky S.H. The Generation of Diversity: Clonal Selection Theory and the Rise of Molecular Immunology. 2000;Harvard University Press.
2. Pauling L. A theory of structure and process of formation of antibodies. J. Am. Chem. Soc. 62:1940;2643-2657.
3. Haurowitz F. The evolution of selective and instructive theories of antibody formation. Cold Spring Harbor Symposium on Quantatative Biology. 32:1967;539-567.
4. Burnet F.M. A modification of Jerne's theory of antibody production using the concept of clonal selection. Australian J Science. 20:1957;67-68.
5. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
6. Tonegawa S. Nobel lecture in physiology or medicine-1987. Somatic generation of immune diversity. In Vitro Cell. Dev. Biol. 24:1988;253-265.
7. Haspel M.V., et al. Multiple organ-reactive monoclonal autoantibodies. Nature. 304:1983;73-76.
8. Dighiero G., et al. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J. Immunol. 131:1983;2267-2272.
9. Ternynck T., Avrameas S. Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities. Immunol. Rev. 94:1986;99-112.
10. Casali P., Notkins A.L. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu. Rev. Immunol. 7:1989;513-535.
11. Prabhakar B.S., et al. Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J. Immunol. 133:1984;2815-2817.
12. Nakamura M., et al. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J. Immunol. 141:1988;4165-4172.
13. Burastero S.E., et al. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J. Exp. Med. 168:1988;1979-1992.
14. Marchalonis J.J., et al. Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans. J. Mol. Recognit. 14:2001;110-121.
15. Cheung S.C., et al. Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli. Clin. Exp. Immunol. 101:1995;383-386.
16. Ichiyoshi Y., Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J. Exp. Med. 180:1994;885-895.
17. Chen C., et al. Natural auto- and polyreactive antibodies differing from antigen-induced antibodies in the H chain CDR3. J. Immunol. 147:1991;2359-2367.
18. Crouzier R., et al. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors. J. Immunol. 154:1995;4526-4535.
19. Harindranath N., et al. Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase. Int. Immunol. 5:1993;1523-1533.
20. Foote J., Milstein C. Conformational isomerism and the diversity of antibodies. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10370-10374.
21. Ma B., et al. Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations. Protein Sci. 11:2002;184-197.
22. Jimenez R., et al. Flexibility and molecular recognition in the immune system. Proc. Natl. Acad. Sci. U. S. A. 100:2003;92-97.
23. Ramsland P.A., et al. Diverse binding site structures revealed in homology models of polyreactive immunoglobulins. J. Comput. Aided Mol. Des. 11:1997;453-461.
24. Rini J.M., et al. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science. 255:1992;959-965.
25. Pinilla C., et al. Elucidation of monoclonal antibody polyspecificity using a synthetic combinatorial library. Pept. Res. 8:1995;250-257.
26. Wedernayer G.J., et al. Structural insights into the evolution of an antibody combining site. Science. 276:1997;1665-1669.
27. Kramer A., et al. Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody. Cell. 91:1997;799-809.
28. Keitel T., et al. Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell. 91:1997;811-820.
29. Bosshard H.R. Molecular recognition by induced fit: how fit is the concept? News Physiol. Sci. 16:2001;171-173.
30. James L.C., et al. Antibody multispecificity mediated by conformational diversity. Science. 299:2003;1362-1367.
31. Fernandez C., et al. Polyreactive binding of antibodies generated by polyclonal B cell activation. II. Crossreactive and monospecific antibodies can be generated from an identical Ig rearrangement by differential glycosylation. Scand. J. Immunol. 45:1997;240-247.
32. Leibiger H., et al. Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding. Biochem. J. 338:1999;529-538.
33. Labrousse H., et al. Effect of temperature on the reactivities of polyreactive and monospecific monoclonal IgG antibodies. Res. Immunol. 148:1997;267-276.
34. McMahon M.J., O'Kennedy R. Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH. J. Immunol. Methods. 241:2000;1-10.
35. Bouvet J.P., et al. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J. Autoimmun. 16:2001;163-172.
36. Casali P., Notkins A.L. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol. Today. 10:1989;364-368.
37. Coutinho A., et al. Natural autoantibodies. Curr. Opin. Immunol. 7:1995;812-818.
38. Bieber A.J., et al. Humoral autoimmunity as a mediator of CNS repair. Trends Neurosci. 24:2001;S39-S44.
39. Parker W. Polyreactive antibodies and their association with xenotransplantation. Xenotransplantation. 10:2003;542-544.
40. Ochsenbein A.F., et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 286:1999;2156-2159.
41. Baumgarth N., et al. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192:2000;271-280.
42. Quan C.P., et al. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect. Immun. 65:1997;3997-4004.
43. Kroese F.G., et al. B-1 cells and their reactivity with the murine intestinal microflora. Semin. Immunol. 8:1996;11-18.
44. Sigounas G., et al. Half-life of polyreactive antibodies. J. Clin. Immunol. 14:1994;134-140.
45. Sigounas G., et al. Polyreactive IgM antibodies in the circulation are masked by antigen binding. J. Clin. Immunol. 14:1994;375-381.
46. Chen Z.J., et al. Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur. J. Immunol. 28:1998;989-994.
47. Wang Z., et al. Characterization of murine polyreactive antigen-binding B cells: presentation of antigens to T cells. Eur. J. Immunol. 31:2001;1106-1114.
48. Wardemann H., et al. Predominant autoantibody production by early human B cell precursors. Science. 301:2003;1374-1377.
49. Julien S., et al. B cell positive selection by soluble self-antigen. J. Immunol. 169:2002;4198-4204.
50. Hayakawa K., et al. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 197:2003;87-99.
51. + B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 277:2002;30707-30715.